Nuveen’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1M Buy
1,304,160
+517,513
+66% +$8.25M ﹤0.01% 1195
2025
Q4
$12.8M Sell
786,647
-389,689
-33% -$6.36M ﹤0.01% 1414
2025
Q3
$17.6M Sell
1,176,336
-66,688
-5% -$813K ﹤0.01% 1230
2025
Q2
$14.5M Sell
1,243,024
-52,093
-4% -$473K ﹤0.01% 1294
2025
Q1
$9.62M Buy
1,295,117
+940,275
+265% +$7.23M ﹤0.01% 1575
2024
Q4
$2.13M Hold
354,842
﹤0.01% 2361
2024
Q3
$1.82M Hold
354,842
﹤0.01% 2459
2024
Q2
$1.28M Sell
354,842
-198,919
-36% -$631K ﹤0.01% 2603
2024
Q1
$1.78M Sell
553,761
-79,456
-13% -$307K ﹤0.01% 2454
2023
Q4
$3.1M Buy
633,217
+4,019
+0.6% +$18.3K ﹤0.01% 2207
2023
Q3
$3.43M Sell
629,198
-117,385
-16% -$776K ﹤0.01% 2055
2023
Q2
$5.01M Sell
746,583
-479,557
-39% -$3.57M ﹤0.01% 1912
2023
Q1
$10.8M Buy
1,226,140
+419,347
+52% +$3.7M ﹤0.01% 1428
2022
Q4
$6.16M Buy
806,793
+359,342
+80% +$2.8M ﹤0.01% 1798
2022
Q3
$3.19M Buy
447,451
+12,861
+3% +$121K ﹤0.01% 2149
2022
Q2
$3.52M Buy
434,590
+109,768
+34% +$965K ﹤0.01% 2152
2022
Q1
$4.11M Buy
324,822
+22,124
+7% +$348K ﹤0.01% 2159
2021
Q4
$8.49M Sell
302,698
-42,034
-12% -$1.29M ﹤0.01% 1797
2021
Q3
$11.7M Sell
344,732
-53,523
-13% -$1.94M ﹤0.01% 1669
2021
Q2
$16.3M Buy
398,255
+21,161
+6% +$823K ﹤0.01% 1530
2021
Q1
$15.2M Sell
377,094
-62,164
-14% -$3.36M ﹤0.01% 1521
2020
Q4
$26M Buy
439,258
+162,942
+59% +$8.4M 0.01% 1077
2020
Q3
$13.4M Buy
276,316
+24,558
+10% +$1.03M 0.01% 1319
2020
Q2
$12.2M Buy
251,758
+15,637
+7% +$570K 0.01% 1351
2020
Q1
$6.56M Buy
236,121
+181,567
+333% +$5.06M ﹤0.01% 1553
2019
Q4
$1.63M Sell
54,554
-1,534
-3% -$44.1K ﹤0.01% 2504
2019
Q3
$1.73M Buy
56,088
+42,718
+320% +$1.74M ﹤0.01% 2464
2019
Q2
$646K Buy
+13,370
New +$592K ﹤0.01% 2916

Other funds holding ADPT